Tag: Cancer: Throat
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
Delaying Treatment Worsens Head, Neck Cancer Outcomes
Findings show that survival declines, recurrence increases with delays of more than 60 days
Most HPV-Linked Cancers Due to Types Targeted by 9vHPV Vaccine
In 2012 to 2016, 92 percent of cancers attributable to HPV due to HPV types targeted by 9vHPV vaccine
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
HPV16-E6 seropositivity increases with shorter lead time, reaching 38.9 percent for <10 years
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation
Since distant metastasis only seen in 3 percent of head, neck cancers, chest CT more cost-effective
Mental Health Disorders Up After Head & Neck Cancer Diagnosis
Women, patients with history of tobacco use, alcohol use have significantly higher odds of MHDs
9/11 Responders May Have Higher Head, Neck Cancer Risk
Authors call for ongoing monitoring, treatment of those initially exposed
